US CDC Recommends Expanding Pneumococcal Vaccines to Adults Aged 50-64
The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5,